Deutsche Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-265,681
Closed -$18.1M 4113
2022
Q3
$18.1M Buy
265,681
+56,371
+27% +$3.84M 0.01% 787
2022
Q2
$6.69M Buy
209,310
+26,906
+15% +$860K ﹤0.01% 1166
2022
Q1
$6.32M Sell
182,404
-124,304
-41% -$4.31M ﹤0.01% 1294
2021
Q4
$8.98M Sell
306,708
-18,659
-6% -$546K ﹤0.01% 1149
2021
Q3
$8.29M Sell
325,367
-55,637
-15% -$1.42M ﹤0.01% 1240
2021
Q2
$13.3M Buy
381,004
+59,849
+19% +$2.1M 0.01% 1057
2021
Q1
$13.1M Buy
321,155
+59,894
+23% +$2.44M 0.01% 1068
2020
Q4
$11.3M Buy
261,261
+91,151
+54% +$3.95M 0.01% 984
2020
Q3
$9.38M Buy
170,110
+64,074
+60% +$3.53M 0.01% 983
2020
Q2
$6.69M Buy
106,036
+11,707
+12% +$739K 0.01% 1153
2020
Q1
$4.82M Sell
94,329
-4,375
-4% -$224K ﹤0.01% 1265
2019
Q4
$7.85M Buy
98,704
+71,519
+263% +$5.68M 0.01% 1217
2019
Q3
$1.32M Sell
27,185
-37,008
-58% -$1.79M ﹤0.01% 2148
2019
Q2
$3.38M Buy
64,193
+44,962
+234% +$2.36M ﹤0.01% 2037
2019
Q1
$1.02M Sell
19,231
-54,376
-74% -$2.87M ﹤0.01% 2962
2018
Q4
$3.02M Sell
73,607
-162,417
-69% -$6.66M ﹤0.01% 2120
2018
Q3
$8.97M Buy
236,024
+99,764
+73% +$3.79M ﹤0.01% 1730
2018
Q2
$6.16M Sell
136,260
-538,898
-80% -$24.4M ﹤0.01% 2140
2018
Q1
$32.6M Buy
675,158
+539,432
+397% +$26.1M 0.02% 835
2017
Q4
$5.34M Sell
135,726
-342,103
-72% -$13.5M ﹤0.01% 1966
2017
Q3
$14.8M Buy
477,829
+193,561
+68% +$6.01M 0.01% 1205
2017
Q2
$7.77M Buy
284,268
+208,356
+274% +$5.7M 0.01% 1581
2017
Q1
$2.79M Buy
75,912
+39,361
+108% +$1.45M ﹤0.01% 2026
2016
Q4
$525K Sell
36,551
-39,766
-52% -$571K ﹤0.01% 3076
2016
Q3
$1.76M Buy
76,317
+49,668
+186% +$1.14M ﹤0.01% 2420
2016
Q2
$440K Buy
26,649
+21,106
+381% +$348K ﹤0.01% 3285
2016
Q1
$87K Sell
5,543
-3,773
-41% -$59.2K ﹤0.01% 3893
2015
Q4
$300K Buy
9,316
+7,410
+389% +$239K ﹤0.01% 3413
2015
Q3
$80K Buy
+1,906
New +$80K ﹤0.01% 3977